Centessa Pharmaceuticals Announces Board and Officer Changes
Ticker: CNTA · Form: 8-K · Filed: May 29, 2025 · CIK: 1847903
| Field | Detail |
|---|---|
| Company | Centessa Pharmaceuticals PLC (CNTA) |
| Form Type | 8-K |
| Filed Date | May 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-changes, officer-compensation
Related Tickers: CNTA
TL;DR
Centessa shuffled its execs and board on 5/27. Watch for compensation details.
AI Summary
Centessa Pharmaceuticals plc announced on May 27, 2025, changes in its board of directors and executive officers. The company also reported on compensatory arrangements for certain officers. This filing is a current report under Section 13 or 15(d) of the Securities Exchange Act of 1934.
Why It Matters
Changes in a company's leadership and executive compensation can signal shifts in strategy or financial health, impacting investor confidence and stock performance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance and executive appointments, not significant financial events or operational disruptions.
Key Players & Entities
- Centessa Pharmaceuticals plc (company) — Registrant
- May 27, 2025 (date) — Date of earliest event reported
FAQ
What specific changes were made to the board of directors?
The filing indicates changes in directors but does not specify the names of departing or newly appointed directors in the provided text.
Who are the certain officers whose compensatory arrangements are being reported?
The filing mentions compensatory arrangements for certain officers but does not name them in the provided text.
What is the exact date of the earliest event reported in this 8-K?
The earliest event reported is dated May 27, 2025.
Under which section of the Securities Exchange Act is this report filed?
This is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the company's primary business as indicated by its SIC code?
The company's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 29, 2025 regarding Centessa Pharmaceuticals plc (CNTA).